NuAx

NuAx was a private U.S. medical device company focused on cardiac rhythm management technologies rather than drug development. Formerly known as Cardia Access, the company developed lead conductor and related device technologies intended to improve pacing, cardiac resynchronization therapy, and defibrillation performance through advances in lead design, placement, sensing, and activation. Its work appears to have centered on implantable cardiovascular hardware for the treatment of heart disease, especially rhythm disorders and heart failure management. Available third-party sources indicate the company raised early-stage financing but was later marked as closed, with no evidence of an approved commercial product portfolio or active clinical-stage therapeutic pipeline.